tbuckley/cabot-search huggingface dataset:
AN APOLOGY.
Journal: JAMA (1893)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
MORE FACTS ABOUT THE GALLBLADDER
Journal: JAMA (1922)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
Correction: <i>Overall survival at 5 years of follow-up in a phase III trial comparing ipilimumab 10 mg/kg with 3 mg/kg in patients with advanced melanoma</i>
Journal: Journal for ImmunoTherapy of Cancer (2020)

Open access Correction: Overall survival at 5 years of follow-up in a phase III trial comparing ipilimumab 10 mg/kg with 3 mg/kg in patients with advanced melanomaAscierto PA, Del Vecchio M, Mackiewicz A, et al.Overall survival at 5 years of follow-up in a phase III trial comparing ipilimumab 10 mg/kg with 3 mg/kg in patients with advanced melanoma.
Gastric varices without esophageal varices. An important preendoscopic diagnosis
Authors: R. P. Rice
Journal: JAMA (1977)

THE ROENTGENOGRAPHIC demonstration of fundal gastric varices by the conventional upper gastrointestinal examination is notoriously difficult.<sup>1-3</sup>Though it is generally believed that most patients with esophageal varices will also have gastric varices, the latter are rarely verified with the conventional upper gastrointestinal examination.<sup>2</sup>The normal gastric rugae frequently have a rather coarse, beaded contour that effectively conceals the dilated veins in the wall of the fundus of the stomach. Gastric fundal varices may assume either a localized polypoid configuration or produce multiple, rounded, submucosal projections throughout the gastric fundus.<sup>4</sup>In either of these situations, the diagnosis of gastric varices may be suspected if the patient has evidence of portal hypertension or pancreatic disease. Doublecontrast examination of the stomach usually provides optimal delineation of polypoid masses in the fundus. Absolute roentgenographic diagnosis depends on opacification of the dilated veins by angiography or splenoportography.<sup>1,2,5</sup> The possibility of gastric
External Diseases of the Eye
Journal: JAMA (1934)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
Section 73.—Appendix IV: Structural Formulae of Drugs Commonly Used in the Treatment of Rheumatic Disease
Journal: JAMA (1973)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
Otolaryngology-Head and Neck Surgery
Authors: Byron J. Bailey
Journal: JAMA (1989)

Foremost among the events of 1988 in our specialty is the creation of a new institute within the National Institutes of Health to serve the needs of those who practice our discipline and the needs of our patients. The new Institute on Deafness and Other Communication Disorders is certain to stimulate many new avenues of basic and clinical investigation and to accelerate the introduction of improved patient care methods and technology into our practices. The implantable electronic cochlear prosthesis is a major new technology that benefits deaf patients. During the past year, the clinical trials of cochlear implantation in children have been completed, and the Food and Drug Administration's Advisory Panel on Ear, Nose and Throat Devices has recommended the approval of the surgically implanted cochlear prosthesis for children. The preponderance of evidence supports its safety and efficacy in children, and it is anticipated that it will greatly benefit social
Massive propranolol therapy and uncomplicated cardiac surgery
Authors: C. J. Kopriva
Journal: JAMA (1978)

CLINICAL practice in several major centers and our recent hemodynamic work<sup>1</sup>support the thesis that therapy with propranolol hydrochloride in moderate doses need not necessarily be discontinued before open heart surgery. However, it is possible that patients who are receiving large doses of propranolol might have adverse responses to anesthesia and operation, particularly if they have suffered recent loss of myocardium. Uncomplicated anesthesia and open heart surgery was performed in a patient who had two recent myocardial infarctions and was taking the equivalent of 2,800 mg of propranolol hydrochloride/70kg/24 hr and who had high preoperative serum propranolol levels. <h3>Report of a Case</h3> A 55-year-old dwarf weighing 40 kg was scheduled for cardiac surgery. Seven months previously he had suffered an anterior myocardial infarction, followed by a repeated infarction six weeks before surgery. Four weeks before surgery, he was admitted to the hospital because of severe, persistent chest pain that
Typographical Errors in Text and Figures
Journal: JAMA Psychiatry (2017)

Andre R. Brunoni, MD, PhD; Anna Chaimani, PhD; Adriano H. Moffa, PsyD, MPhil; Lais B. Razza, PsyD; Wagner F. Gattaz, MD, PhD; Zafiris J. Daskalakis, MD, PhD; Andre F. Carvalho, MD, PhD
Sensible drinking
Authors: G. Edwards
Journal: BMJ (1996)

<h3>Objectives</h3> Limited data are available regarding the predictive value of electrocardiographic T wave inversion in lead aVL for mid-segment left anterior descending (MLAD) lesions among patients with acute coronary syndrome (ACS). <h3>Setting</h3> Retrospective single-centre study, using a prospectively-collected coronary angiography database from January 2012 to December 2013. <h3>Participants</h3> We included consecutive adult patients with ACS who underwent urgent percutaneous coronary intervention (PCI) within 24 h after arriving at the hospital. We excluded patients who did not undergo an ECG before PCI, patients with proximal MLAD occlusion and patients diagnosed with vasospastic angina. <h3>Primary and secondary outcome measures</h3> The primary outcome was MLAD lesion &gt;50%. The other outcome of interest was MLAD lesion as a cause of ACS. First, we evaluated the diagnostic values of T wave inversion in lead aVL regardless of other T wave changes for each outcome. Second, we evaluated the diagnostic values of isolated T wave inversion in lead aVL. <h3>Results</h3> Overall, 219 patients were eligible for the analysis. T wave inversion in lead aVL regardless of other T wave changes had a sensitivity of 32.9%, specificity of 48.2%, positive predictive value of 27.6% and negative predictive value of 54.5% for predicting MLAD lesions. Isolated T wave inversion in lead aVL had a sensitivity of 9.8%, specificity of 86.9%, positive predictive value of 30.8% and negative predictive value of 61.7% for predicting MLAD lesions. These diagnostic values did not change materially when focusing on patients with MLAD lesion as the cause. <h3>Conclusions</h3> While T wave inversion in lead aVL regardless of other T wave changes had low diagnostic values for predicting MLAD lesions, isolated T wave inversion in lead aVL had a high specificity. Our inferences underscore the importance of a cautious interpretation of T wave inversion in lead aVL among patients with ACS.
Medical Promotions in the Navy.
Journal: JAMA (1892)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
More RIpH
Authors: Anchi Wu
Journal: JAMA (1992)

<h3>To the Editor.</h3> —I read with interest the letter by Neiberger<sup>1</sup>as this issue was raised before in the 1970s.<sup>2</sup>I believe that there are typing errors in the sentence, "In the days of Arrhenius, Severinghaus, and Henderson-Hasselbalch...." S. A. Arrhenius (1859-1927) was a Swedish chemist and physicist.<sup>3</sup>L. J. Henderson (1878-1942) was a Boston, Mass, physiologist.<sup>4</sup>H. A. Hasselbalch (1874-1962) was a Copenhagen biochemist.<sup>4</sup>J. W. Severinghaus is the inventor of the commonly used Stow-Severinghaus CO<sub>2</sub>electrodes and is a distinguished professor in anesthesiology at the University of California, San Francisco. Severinghaus does not belong to the bygone era. I think Neiberger really meant to type, "In the days of Arrhenius, Sorenson, Henderson, and Hasselbalch...." S. P. L. Sorenson (1868-1939) was a Copenhagen biochemist who invented the pH system in 1909.<sup>3</sup>
Romanian health and social care system for children and families: future directions in health care reform. Children's Health Care Collaborative Study Group.
Authors: P Stephenson
Journal: BMJ (1992)

small rural communities that existed in the Wadi Halfa area around AD 350-550.Settlement in this part of Lower Nubia began during the Meroitic period (first century BC), when the introduction of the ox driven water wheel meant that water could be lifted to irrigate fields in an area where the lack of rainfall (<25 mm a year) and the deeply incised river channel had pre- viously prevented cultivation by traditional means.'3As agriculture in this region of Sudan was possible only with intensive water lift irrigation, conditions were well suited for snail vectors for schistosomiasis in irrigation channels in perennially irrigated fields, circumstances that still provide an important habitat for the intermediate host of the parasite.'3Nowadays schistosomiasis is endemic in most inhabited parts of southern Egypt and northern Sudan.The positivity rate we found is within the range of modern rates of infection in the study area and other perennially irrigated areas of the Nile valley.The application of a sensitive and specific immunological assay for schistosomiasis to mummies shows that with modern biomedical assays it is possible to move beyond the detection of isolated cases of ancient disease to determining trends in ancient public health.
Dyslexia
Authors: Drake D. Duane
Journal: JAMA (1989)

<h3>To the Editor.—</h3> We wish to congratulate<i>JAMA</i>and the Council on Scientific Affairs<sup>1</sup>for the excellent article on dyslexia. It brings out the point that dyslexia is a problem due to the structural characteristics of the brain and as such is a responsibility not only of the educator but of the physician as well. We wish to add some additional information that may be helpful to physicians encountering dyslexic individuals. There is now strong evidence that the disabilities of persons with dyslexia stem from anomalies (or characteristics) of brain development. Positron emission tomography scan (M. Reichle, MD, et al, oral communication, March 1989) and computerized electroencephalogram studies<sup>2</sup>reveal differences in brain function. Galaburda et al<sup>3,4</sup>have now studied the brains of nine persons with dyslexia. In every one, they have found numerous heterotopias in the cortex, especially in the perisylvian areas. Similar changes have not been
Reduction of Methemoglobin in Erythrocytes of a Patient with Congenital Methemoglobinemia, Subjects with Erythrocyte Glucose-6-Phosphate Dehydrogenase Deficiency, and Normal Individuals
Journal: JAMA (1963)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
VECTORCARDIOGRAPHY
Authors: T. East
Journal: BMJ (1957)

<h3>Introduction</h3> Methodologically robust clinical trials are required to improve neonatal care and reduce unwanted variations in practice. Previous neonatal research prioritisation processes have identified important research themes rather than specific research questions amenable to clinical trials. Practice-changing trials require well-defined research questions, commonly organised using the Population, Intervention, Comparison, Outcome (PICO) structure. By narrowing the scope of research priorities to those which can be answered in clinical trials and by involving a wide range of different stakeholders, we aim to provide a robust and transparent process to identify and prioritise research questions answerable within the National Healthcare System to inform future practice-changing clinical trials. <h3>Methods and analysis</h3> A steering group comprising parents, doctors, nurses, allied health professionals, researchers and representatives from key organisations (Neonatal Society, British Association of Perinatal Medicine, Neonatal Nurses Association and Royal College of Paediatrics and Child Health) was identified to oversee this project. We will invite submissions of research questions formatted using the PICO structure from the following stakeholder groups using an online questionnaire: parents, patients, healthcare professionals and academic researchers. Unanswered, non-duplicate research questions will be entered into a three-round eDelphi survey of all stakeholder groups. Research questions will be ranked by mean aggregate scores. <h3>Ethics and dissemination</h3> The final list of prioritised research questions will be disseminated through traditional academic channels, directly to key stakeholder groups through representative organisations and on social media. The outcome of the project will be shared with key research organisations such as the National Institute for Health Research. Research ethics committee approval is not required.
ERCP Topics
Authors: P Connor, R H Hawes
Journal: Endoscopy (2001)

Endoscopic retrograde cholangiopancreatography (ERCP) remains the gold standard for pancreaticobiliary ductal imaging. Over the last few years, the quality of imaging produced by magnetic resonance cholangiopancreatography (MRCP) has improved greatly, and indeed in some specialist centers it has supplanted ERCP as a diagnostic test. However, there is still confusion regarding the place of MRCP in the investigational algorithm of patients with suspected pancreaticobiliary disease-whether or not it avoids the need for ERCPs, and if so, whether it is cost-effective in doing so.
CATERPILLAR DERMATITIS
Authors: M Chandrasekaran, R Mensah
Journal: JAMA (1922)

Lepidopterism is the term used to describe the aggregate adverse medical effects resulting from contact with adult or larval forms of butterflies and moths. Histamine, histamine-releasing substances, kinin activators, and other as yet undefined proteins are responsible for cutaneous, cardiovascular, neurologic, and constitutional signs and symptoms of lepidopterism. Insect venom is likely injected into the skin through specialized caterpillar hairs when contact occurs with the insect (or vegetation laden with insect debris). Mild cases of lepidopterism will resolve spontaneously; systemic corticosteroids may aid in the treatment of more serious cases.
Nodding Syndrome Prevalence
Journal: JAMA (2014)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
Evaluation of in vitro and in vivo gene transfer into cardiac myocytes and endothelial cells using multiply attenuated, self-inactivating lentiviral vectors Eleonora Simeoni, Sylvain Fleury, Robert Driscoll, Ludwig K. von Segesser, Lukas Kappenberger, Giuseppe Vassalli. Division of cardiology, Lausanne, Switzerland
Journal: Journal of the American College of Cardiology (2001)
Lancet, London
Journal: JAMA (1962)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal